Campbell Bradley L Insider Trades

Insider Trading History

Track insider trading activity for Campbell Bradley L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$43.1M 2,973,089 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $14.5M 998,680 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$323k 22,500 shares
$14.35
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $14.8M 1,021,180 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.07M 75,000 shares
$14.31
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $15.9M 1,096,180 shares
Last Trade
Jan 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.07M 75,000 shares
$14.31
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.07M 75,000 shares
$14.31
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $14.8M 1,021,180 shares
Last Trade
Dec 26, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.55M 108,602 shares
$14.25
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.4M 1,129,782 shares
Last Trade
Dec 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$846k 77,926 shares
$10.86
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $17.5M 1,207,708 shares
Last Trade
Dec 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$767k 70,426 shares
$10.89
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $0 0 shares
Last Trade
Dec 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$767k 70,426 shares
$10.89
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $1.02M 70,426 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$132k 14,587 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.5M 1,137,282 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$146k 14,587 shares
$10.01
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.7M 1,151,869 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$132k 14,587 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.5M 1,137,282 shares
Last Trade
Nov 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$146k 14,587 shares
$10.04
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.7M 1,151,869 shares
Last Trade
Nov 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$132k 14,587 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $1.23M 85,013 shares
Last Trade
Nov 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$132k 14,587 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.5M 1,137,282 shares
Last Trade
Mar 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$119k 13,375 shares
$8.90
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.7M 1,151,057 shares
Last Trade
Feb 19, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.61k 400 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.7M 1,150,657 shares
Last Trade
Feb 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4k 400 shares
$10.00
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $1.44M 99,600 shares
Last Trade
Feb 19, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.61k 400 shares
$9.03
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
President And CEO
Holding Value $16.7M 1,150,657 shares
Last Trade
Feb 11, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$677k 70,711 shares
$9.57
$14.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up